Skip to main content
  • Saved



Will this make you re-think prescribing?

Small-molecule CGRP receptor antagonists may pose a risk during stroke

Small-molecule CGRP receptor antagonists may pose a risk during stroke

Source : https://www.mdedge.com/neurology/migraineresourcecenter/article/220932/headache-migraine/small-molecule-cgrp-receptor

"It turns out that these drugs make the blood vessels of the brain dysfunctional, such that the collateral channels that bring in blood to the region that is having the stroke are impaired," explains the study's lead author, Cenk Ayata, MD, associate professor of neurology and radiology at Harvard Medical School, Boston.